Search Results 1661-1670 of 21318 for anti-TNF drugs
Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...
Any previous treatment with systemic anti cancer immunotherapy, including but not limited to anti-PD-1, anti-PD-L1, and anti-CTLA-4 agents. For Part 1 ...
Tiotropium belongs to the family of medicines known as bronchodilators. Bronchodilators are breathed in through the mouth to help open up the bronchial ...
Rituximab, an anti-CD20 chimeric antibody, was approved by the United States Food and Drug Administration in 1998 for the treatment of patients with relapsed ...
... anti-IgG or anti-IgA. Have failed or not tolerated at least one prior wAIHA treatment regimen, including steroids, rituximab, azathioprine, cyclophosphamide ...
Proper Use. Drug information provided by: Merative, Micromedex®. Take this medicine only as directed by your doctor. Do not take more of it, do not take it ...
specific antibodies (anti-GP210 and/or anti-SP100 and/or antibodies against the major M2 components [PDC-E2, 2-oxo-glutaric acid dehydrogenase complex]) 3 ...
Side Effects. Drug information provided by: Merative, Micromedex®. Along with its needed effects, a medicine may cause some unwanted effects. Although not ...
Herbal medications with unknown properties or known beneficial effects for AD. Within 1 week of first dose of investigational product: Anti-platelet drugs.
We have conducted preliminary studies of combination anti-PD-1 and anti-PD-L1 ICI treatment on B16 tumors. Once inoculated, tumors rapidly grew logarithmically ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift before July 31 and it can go twice as far to fight cancer.